View Author
dai: 073036838
scopus: 7102665508
Burger, C.W.
(Curt Burger)Supervisor (promotor) of 4 dissertations
cancer patient women study endometrial expression group treatment tibolone receptor analysis result factor stage surgery progesterone estrogen table breast tumor disease netherland effect gynecol endometrium level endometrial cancer incontinence symptom response protein number tissue carcinoma control survival tamoxifen serum prolapse floor breast cancer muscle population questionnaire growth mutation sample regulation figure rotterdam erasmu pathway deletion obstet organ prolapse cycle department contraction signi proliferation erasmus univ rotterdam university assessment pgrcre /+ cytoreductive surgery presence prevalence oncol activity difference recurrence wnt /b risk factors chemotherapy model postmenopausal ishikawa amg 479 metabolite journal
10 Most Recent Publications
|
Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity
(Article)
Driessen, G.J.A. IJspeert, H. Zelm, M.C. van Dongen, J.J.M. van Deuren, M. van Burger, C.W. Weemaes, C.M.R. Haraldsson, A. Trip, M. Warris, A. Flier, M. van der Wulffraat, N.M. Verhagen, M.M.M. Taylor, M.A. |
2013-04-08
|
|
Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression
(Article)
Zee, M. van der Jia, Y. Blok, L.J. Wang, Y. Heijmans-Antonissen, C. Ewing, P.C. Franken, P.F. Demayo, F.J. Lydon, J.P. Burger, C.W. Fodde, R. |
2013-03-18
|
|
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hooning, M. Menke-Pluymers, M.B.E. Heemskerk-Gerritsen, B.A.M. Doorn, L.C. van Collee, J.M. Jager, A. Montfort, C.A.G.M. van Burger, C.W. |
2013-03-01
|
|
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer
(Article)
Horst, P.H. van der Wang, Y. Put, I. van den Kühne, L.C. Ewing, P.C. IJcken, W.F.J. van Zee, M. van der Amant, F. Burger, C.W. Blok, L.J. |
2012-01-25
|
|
New frontiers of primary antibody deficiencies
(Article)
Burger, C.W. Zelm, M.C. van Driessen, G.J.A. Dongen, J.J.M. van |
2012-01-01
|
|
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
(Article)
Leeuwen, F.E. van Klip, H. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. Veen, F. van der Evers, J.L.H. Dop, P.A. van Macklon, N.S. Burger, C.W. Mooij, T.M. Swaluw, A.M.G. van de Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. |
2011-12-01
|
|
The prevalence and factors associated with previous surgery for pelvic organ prolapse and/or urinary incontinence in a cross-sectional study in the Netherlands
(Article)
Boer, T.A. de Slieker-Ten Hove, M.C.P. Burger, C.W. Vierhout, M.E. Kluivers, K.B. |
2011-10-01
|
|
AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways
(Article)
Mendivil, A. Zhou, C. Cantrell, L.A. Gehrig, P.A. Malloy, K.M. Blok, L.J. Burger, C.W. Bae-Jump, V.L. |
2011-09-01
|
|
Interaction between sexhormones and WNT/β-catenin signal transduction in endometrial physiology and disease
(Article)
Horst, P.H. van der Wang, Y. Zee, M. van der Burger, C.W. Blok, L.J. |
2011-07-14
|
|
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hoogwerf, D. Beugelink, S. Burg, M.E.L. van der Hooning, M. Berns, P.M.J.J. Jager, A. Collée, J.M. Burger, C.W. |
2011-06-06
|
